HEMANT MURTHY, M.D.
Hematology & Oncology Physician · JACKSONVILLE, FL
Individual Active NPI 1518129188
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 698 | 100,145 | $10,868,999 | $2,860,911 | $2,280,293 |
| 2023 | 677 | 102,097 | $9,220,599 | $2,340,639 | $1,861,560 |
| 2022 | 722 | 114,097 | $9,970,444 | $2,594,780 | $2,079,716 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 10,200 | $51 | $40 |
| Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 7,680 | $0 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 7,050 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 6,880 | $31 | $25 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 5,060 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 4,140 | $49 | $39 |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 4,000 | $13 | $11 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 3,860 | $3 | $2 |
| J0897 | Injection, denosumab, 1 mg | 2,640 | $25 | $20 |
| J9267 | Injection, paclitaxel, 1 mg | 2,232 | $0 | $0 |
| J9173 | Injection, durvalumab, 10 mg | 1,810 | $80 | $64 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,560 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | ME124262 | FL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Florida
- NPI 1720428170
- NPI 1114351574
- NPI 1316642333
- NPI 1023690104
- NPI 1184157539
- NPI 1174200281
- NPI 1952390684
- NPI 1891082582
See all Hematology & Oncology Physician providers in Florida →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.